Wednesday, April 10, 2019 Daily Archives

ChromaCon buy and expansions tip YMC further into the biologics space

by

Japanese separation resins firm YMC has acquired ChromaCon AG, adding a range of continuous chromatography technologies to its ever-increasing large molecules purification portfolio. The deal, financials of which have not been released, saw YMS acquire 100% of ChromaCon shares and intellectual property rights. This includes patents around multi-column processing, the Contichrom benchtop instrument range of products and several license arrangements. “YMC Process Technologies already manufactures and markets GMP production skids embedding ChromaCon technology,†Philipp Anstätt, strategist aligning R&D and market…

April 10, 2019

Celltrion jumps into ADC space through Canadian partnership

by

Celltrion has inked a deal with iProgen Biotech to develop a pipeline of antibody-drug conjugates (ADCs). While best known for its portfolio of marketed biosimilars, Korean drugmaker Celltrion has been investing in its internal R&D for novel biotherapeutics and has five antibodies in development for diseases ranging from rabies to influenza. Now the firm is aiming to develop up to four antibody-drug conjugates (ADCs), including one targeting breast cancer, through a partnership agreement with Canadian firm iProgen Biotech. Financial details…

April 10, 2019